Medium-term rat liver bioassay for rapid detection of carcinogens and modifiers of hepatocarcinogenesis.

For rapid detection of carcinogenic agents, a medium-term liver bioassay has been established in our laboratory using preneoplastic glutathione S-transferase placental form (GST-P) positive foci in the rat liver as endpoint marker lesions. A total of 237 compounds have so far been tested in this system and the results compared with reported Salmonella/microsome and long-term carcinogenicity test findings. The positive rate was found to be extremely high, 97% (28 of 29 compounds) for genotoxic hepatocarcinogens; and satisfactory, 86% (23 of 27 chemicals) for nongenotoxic ones. The positive rate for carcinogens targeting organs other than the liver, however, is relatively low (24%). Malathion and vinclozolin proved positive, although both have been reported to be noncarcinogenic in rats and mice. Those chemicals which exerted positive results in this system might be hepatopromoting agents even if hepatocarcinogenicity has not been established. Five of the six false-negative hepatocarcinogens could be categorized as peroxisome proliferators. In addition, a number of inhibitory agents for GST-P-positive foci development have been detected and many are categorized as antioxidants. The validity of this system as a tool for rapid detection of carcinogenic and chemopreventive agents is discussed.

[1]  E Zeiger,et al.  Carcinogenicity of mutagens: predictive capability of the Salmonella mutagenesis assay for rodent carcinogenicity. , 1987, Cancer research.

[2]  H. Rosenkranz,et al.  The structural basis of the mutagenicity of chemicals in Salmonella typhimurium: the Gene-Tox data base. , 1990, Mutation research.

[3]  K. Imaida,et al.  Strategy of research for cancer--chemoprevention. , 1992, Teratogenesis, carcinogenesis, and mutagenesis.

[4]  D. Brusick,et al.  The Salmonella typhimurium/mammalian microsomal assay. A report of the U.S. Environmental Protection Agency Gene-Tox Program. , 1986, Mutation research.

[5]  M. Hirose,et al.  Suppression of Diethylnitrosamine‐initiated Preneoplastic Foci Development in the Rat Liver by Combined Administration of Four Antioxidants at Low Doses , 1992, Japanese journal of cancer research : Gann.

[6]  T Sofuni,et al.  A comparative analysis of data on the clastogenicity of 951 chemical substances tested in mammalian cell cultures. , 1988, Mutation research.

[7]  N Ito,et al.  Enhancing effect of various hepatocarcinogens on induction of preneoplastic glutathione S-transferase placental form positive foci in rats--an approach for a new medium-term bioassay system. , 1988, Carcinogenesis.

[8]  S. Fukushima,et al.  Modifying Effects of Various Chemicals on Preneoplastic and Neoplastic Lesion Development in a Wide‐spectrum Organ Carcinogenesis Model Using F344 Rats , 1991, Japanese journal of cancer research : Gann.

[9]  H. Pitot,et al.  Models of hepatocarcinogenesis in the rat--contrasts and comparisons. , 1986, Critical reviews in toxicology.

[10]  R. Tennant,et al.  Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the U.S. NTP. , 1991, Mutation research.

[11]  E. Farber.  Origins of Human Cancers , 1985, Toxicologic pathology.

[12]  N. Ito,et al.  Enhancement by non-mutagenic pesticides of GST-P positive hepatic foci development initiated with diethylnitrosamine in the rat. , 1993, Cancer letters.

[13]  L. Bernstein,et al.  Summary of carcinogenic potency and positivity for 492 rodent carcinogens in the carcinogenic potency database. , 1989, Environmental health perspectives.

[14]  P Bannasch,et al.  Preneoplastic lesions as end points in carcinogenicity testing. I. Hepatic preneoplasia. , 1986, Carcinogenesis.

[15]  M. A. Moore,et al.  Hepatocarcinogenesis in the rat: the effect of promoters and carcinogens in vivo and in vitro. , 1986, International review of cytology.

[16]  J. Huff,et al.  Carcinogenesis studies of 4,4'-methylenedianiline dihydrochloride given in drinking water to F344/N rats and B6C3F1 mice. , 1986, Journal of toxicology and environmental health.

[17]  B. Ames,et al.  Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test. , 1975, Mutation research.

[18]  M. Rao,et al.  Phenotypic Properties of Liver Tumors Induced by Dehydroepiandrosterone in F‐344 Rats , 1992, Japanese journal of cancer research : Gann.

[19]  N. Ito,et al.  Liver medium-term bioassay in rats for screening of carcinogens and modifying factors in hepatocarcinogenesis. , 1992, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[20]  M. Rao,et al.  Peroxisome proliferation and hepatocarcinogenesis. , 1987, IARC scientific publications.

[21]  S. Fukushima,et al.  Medium-term bioassay for carcinogens using multiorgan models. , 1991, Progress in experimental tumor research.

[22]  K. Imaida,et al.  Rapid bioassay methods for carcinogens and modifiers of hepatocarcinogenesis. , 1989, Critical reviews in toxicology.

[23]  M. Hirose,et al.  Antioxidants--carcinogenic and chemopreventive properties. , 1989, Advances in cancer research.

[24]  H. Vainio,et al.  Carcinogenic properties of pharmaceutical agents evaluated in the IARC Monographs programme. , 1991, Carcinogenesis.

[25]  D. Bleyl,et al.  IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs vol. 1 to 42. Supplement 7. 440 Seiten. International Agency for Research on Cancer, Lyon 1987. Preis: 65, – s.Fr , 1989 .

[26]  M. Tatematsu,et al.  Organ‐specific Modification of Tumor Development by Low‐dose Combinations of Agents in a Rat Wide‐spectrum Carcinogenesis Model , 1991, Japanese journal of cancer research : Gann.